Back to search
NY-ESO-1 Expressing Solid Tumors in HLA-A2 Positive Patients
Clinical trial pipeline · Data from ClinicalTrials.gov
See which NY-ESO-1 Expressing Solid Tumors in HLA-A2 Positive Patients trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which NY-ESO-1 Expressing Solid Tumors in HLA-A2 Positive Patients trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The target populations for this phase I study with TBI-1301 are patients with advanced solid tumors. Patients' tumors will be required to express NY-ESO-1, whic…
New York Esophageal Squamous Cell Carcinoma 1 (NY-ESO-1) is a Cancer-Testis Antigen (CTA) which is expressed in various tumors. After selected the high affinity…